Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology | Pulmonary/Respiratory Diseases | Psychiatry/Psychology
Disease Category: Sleep Apnea Syndromes
Trial Information
Do you suffer from Sleep Apnea and Depression with Excessive Daytime Sleepiness?
Trouble staying awake during the day?
Every morning, thousands of people with obstructive sleep apnea (OSA) and depression wake up tired. The purpose of this research study is to determine if an FDA-approved drug for reducing daytime sleepiness in people with treated OSA is also effective in people with treated OSA and depression.
Who qualifies for this study?
If you are between the ages of 18 and 65 years old, you may qualify for this study if:
- You have daytime sleepiness caused by obstructive sleep apnea
- You use CPAP therapy to treat your apnea
- You are taking a prescription medication for depression
Patient Exclusion Criteria: Patients who have a confirmed or suspected diagnosis of a currently active sleep disorder other than Obstructive Sleep Apnea/Hypopnea.
Patrice Harris, Research Assistant
Neurotrials Research, Inc.
1100 Johnson Ferry Road NE, Suite 420
Atlanta, GA 30342
Phone: 404-851-9934
Fax: 404-851-9458
EMail: pharris@neurotrials.com
View Google Map
Research Center Information: Neurotrials Research, Inc.
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
